What is the UMB Institute for Clinical & Translational Research (ICTR)?
The UMB ICTR is a clinical translational research initiative supported by the UMB campus.
The UMB ICTR is a campuswide clinical translational research initiative supported by the UMB campus. The UMB ICTR provides financial support as well as infrastructure, environment, training, and workforce to invigorate, facilitate, and accelerate clinical translational research to improve patient and community health. This site will highlight ICTR-supported resources as well as other campuswide shared resources and community-engagement activities. If you are unsure of the "next steps" or have problems with the ICTR website, please email ICTR Research Navigator and visit this site often for new and expanding UMB ICTR resources. To learn more about UMB ICTR and the tremendous support from the UMB campus, visit About UMB ICTR.
April 25, 2018 | The University of Maryland, Baltimore (UMB) Institute for Clinical and Translational Research (ICTR) is pleased to announce the first round of awardees of the Accelerated Translational Incubator Pilot (ATIP) grants. ICTR’s financial support (up to $50,000 per grant) is designed to foster new collaborations between faculty members across UMB schools and between UMB faculty and community partners.
April 24, 2018 | The CTSA program helps support high quality translational and clinical research locally, regionally, and nationally and fosters innovation in research methods, training, and ...
March 01, 2018 | The UMB Voucher Program awards vouchers (micro grants) to enable preliminary work and generation of pilot data on clinical and translational research projects and to defray the cost of non-ICTR Core services as well as community engagement research expenses. UMB faculty with IRB-approved ATIP grants, K awards, or other federally-funded or extramural, peer-reviewed grants may be eligible for up to $10,000 in voucher support. Other UMB faculty may be eligible for voucher support up to $5,000.